Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-06

Clinical Trial Update: PKU Carriers Trial (Pilot Study): Impact on Cognition, Mental Health, Blood Pressure and Metabolism [NA]

View source ↗

Summary

The University of Guelph is conducting a pilot study in genetic PKU carriers to evaluate effects on cognition, mental health, blood pressure, and metabolism. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Guelph | Conditions: Autosomal Recessive Disorder (Genetic Carriers of PKU) | NA | Status: COMPLETED